A panel of melanoma cell lines, harboring wild type or mutant BRAF and NRAS, showed sensitivity to the six EOs, even if at a different extend, thus indicating that the effect of EOs was not related to BRAF or NRAS status. The gene discussed is NRAS; the disease is melanoma.